• Search
  • Home
  • New
  • Top Charts

Government

  • سقراط مع عمر الجريسي
    سقراط مع عمر الجريسي

    1

    سقراط مع عمر الجريسي

    ثمانية/ thmanyah

  • طاهر المعتز بالله - ماذا يحدث؟
    طاهر المعتز بالله - ماذا يحدث؟

    2

    طاهر المعتز بالله - ماذا يحدث؟

    Taher El Moataz Bellah

  • الحل إيه؟ مع د. رباب المهدي
    الحل إيه؟ مع د. رباب المهدي

    3

    الحل إيه؟ مع د. رباب المهدي

    Alternative Policy Solutions - حلول للسياسات البديلة

  • The HSE Podcast
    The HSE Podcast

    4

    The HSE Podcast

    hsepodcast

  • الحل إيه؟ مع د. رباب المهدي
    الحل إيه؟ مع د. رباب المهدي

    5

    الحل إيه؟ مع د. رباب المهدي

    Alternative Policy Solutions - حلول للسياسات البديلة

  • British Council Language Assistants
    British Council Language Assistants

    6

    British Council Language Assistants

    British Council

  • The Lawfare Podcast
    The Lawfare Podcast

    7

    The Lawfare Podcast

    The Lawfare Institute

  • بيع أصول الدولة مع نيفين الطاهري | الحل أيه؟

    8 May

    بيع أصول الدولة مع نيفين الطاهري | الحل أيه؟

    في هذه الحلقة من بودكاست #الحل_إيه؟ مع د. رباب المهدي، نفتح واحداً من أهم الملفات الاقتصادية في مصر: "بيع أصول الدولة". نناقش الفرق بين برنامج الطروحات الحالي وبرنامج الخصخصة الذي بدأ في منتصف التسعينيات وبداية الألفية الجديدة، وما شابه من إخفاقات وتعثرات. وتشرح لنا ضيفة الحلقة نيفين الطاهري، العضو السابق بمجلسي إدارة الصندوق السيادي المصري والبورصة المصرية، سياسات تخارج الدولة التي تتنوع بين البيع الكلي والجزئي، والآليات التي تعتمدها الحكومة لإعادة هيكلة ملكيتها، بدءاً من إنشاء الصندوق السيادي وصولاً إلى إصدار وثيقة سياسة ملكية الدولة. كما نسلط الضوء على الأسباب الحقيقية وراء بطء برنامج الطروحات، والتحديات الهيكلية والتشريعية التي تعرقل سرعة تنفيذه على أرض الواقع. Hosted on Acast. See acast.com/privacy for more information.

  • ماذا حدث في دمياط؟

    1 day ago

    ماذا حدث في دمياط؟

    من وراء المسيرة؟

  • دراية: من حافة الإفلاس إلى إدارة المليارات

    2 Jun

    دراية: من حافة الإفلاس إلى إدارة المليارات

    من شركة كانت على حافة الانهيار في 2011، إلى واحدة من أكبر شركات الاستثمار في السوق السعودي. ضيفنا في هذه الحلقة محمد الشماسي، الرئيس التنفيذي لشركة «دراية المالية»، يشرح كيف تُدار أسواق المال من الداخل، وكيف تُبنى الثروات بعيدًا عن الصورة التقليدية التي يراها المستثمرون. يروي كيف بدأت «دراية المالية» من قلب أزمة انهيار الأسهم في 2006، وكيف قلبت موازين القطاع المالي بالتخلي عن عمولات التداول، وصولًا إلى توسّعها عند تأسيس البنك الرقمي «دال 360». في جانب الاستثمار، يكشف تفاصيل خسارة وصلت إلى 70% من رأس المال في استثمار آسيوي، مقابل أرباح مضاعفة في استثمارات مبكرة في شركات عالمية مثل «سبيس إكس». حلقة تكشف ما يحدث فعليًّا داخل الأسواق: كيف تُبنى القرارات، وكيف تُرتكب الأخطاء، وكيف تتشكل الثروة بعيدًا عن الانطباعات الحالمة. ـــــ • اسمع هذه الحلقة وغيرها من الحلقات بدون موسيقا عند اشتراكك في «راديو ثمانية». • تابع فلم فلان «سواقنا» على تطبيق ثمانية. • فرصة للمهتمين: فريق سقراط يبحث عن أشخاص شغوفين للعمل معه. لو مهتم، قدّم عبر الرابط. • صفا للاستثمار، حلول سكنية راقية تلبي احتياجك وتسبق توقعاتك. • المشتل، منصة إبداعية بمعامل مجهزة لكل شخص مهتم بتطوير نفسه ومهاراته. • تابع أخبار الكرة وسياقاتها أولًا بأول في نشرة «مصدر مطلع»

  • Lawfare Daily: Ukraine, Iran, Taiwan, and the Short War Illusion

    14 hr ago

    Lawfare Daily: Ukraine, Iran, Taiwan, and the Short War Illusion

    Some countries are susceptible to believing that with the right military strategy, they can accomplish their goals with a quick war. It's called the "Short War Illusion," and as the term suggests, it rarely works out as planned. That includes the two major conflicts currently underway in Ukraine and Iran. And it could include a potential conflict in Taiwan. On today's podcast, Executive Editor Natalie Orpett speaks with Dara Massicot, Senior Fellow at the Carnegie Endowment’s Russia & Eurasia Program; Ariane Tabatabai, Vice President at the Chicago Council on Global Affairs and a contributing editor at Lawfare, and Julia Curlee, Lawfare Public Service Fellow and 25-year veteran of the CIA. They discuss how the short war illusion is playing out today and how it could play out in a future conflict between China and Taiwan—a topic Julia considered in her recent piece in Lawfare, “The Short-War Illusion: What Iran Teaches Beijing About Taiwan.” To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute. Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

  • After UK Transition: Working with Chemicals - Episode 2 - BPR

    21/12/2020

    After UK Transition: Working with Chemicals - Episode 2 - BPR

    After UK Transition: Working with Chemicals - Episode 2 - BPR In this episode, we are joined by two HSE experts in Dr Nicola Gregg - Biocides Operational Policy Team Leader and Dr Pierre Cruse - International Chemicals Unit Team Leader. We discuss the changes that will have the greatest impact on businesses following the end of the UK Transition period, how to get an active substance approved in both the EU and GB and how companies can get on the GB version of Article 95. ----more----Visit our website for further information and detailed guidance on biocidal product regimes. If you have any concerns regarding UK Transition and changes to Biocide regimes, contact HSE at the earliest opportunity via biocidesenquiries@hse.gov.uk   Podcast Transcription  Welcome to the latest HSE Podcast with me, Mick Ord.   This month, with the help of our resident experts, we’ll be guiding you through the new Biocidal Products Regulations – that’s BPR to you and me - and how the new regulatory framework will affect your business as we leave the EU and the transition period comes to an end. We’ll be finding out what you should be doing now and will be required to do in the future under the new GB regulations and how that will affect companies in Great Britain and Northern Ireland. Now we’ve left the EU, many of the functions currently being carried out by Europe will soon be transferred to Great Britain but certain EU functions have been removed and we’ll be highlighting these areas and explaining what you need to do to make sure you comply with the new arrangements. Over the next half hour or so we’ll be addressing many of the issues that are concerning businesses and pointing you in the right direction -  so without further ado, let me introduce you to 2 people whose knowledge of the new BPR framework is second to none.  Dr Nicola Gregg and Dr Pierre Cruse are both from the HSE.  Nicola is team leader for Biocides Operational Policy in the HSE’s Chemicals Regulation Directorate and Pierre is team leader at the HSE’s International Chemicals Unit – his team is responsible for developing Government policy on biocides and also the CLP regulations – that‘s the classification, labelling and packaging of substances and mixtures. I’ll start with you if I may Pierre - Will the new GB framework for Biocides be the same as the EU framework? Pierre: I think the answer is in some ways yes and some ways no.  From the 1st January next year, 2021, Great Britain is going to have its own independent regulatory framework for biocidal products.  It’s going to reflect the current EU framework, the EU Biocidal Products Regulation, but they are going to operate independently of each other.  Essentially, the rules and standards are going to be pretty much the same, but some elements to the framework won’t exist, basically those bits that refer to EU processes and institutions that we’ll no longer be dealing in the national system. Mick: So in what areas will it be different? Pierre: The Great Britain Biocidal Products Regulations – BPR – we call it a lift and shift of the EU’s BPR. What that means essentially is that we copied it into domestic law without any policy changes.  The only bits that have changed are those  which wouldn’t operate correctly in the new Great Britain context, as I say, the bits that refer to European Institutions, the European Chemicals Agency and the European Commission are examples of that.  So for example ECHA, functions that previously sat with ECHA are now going to be transferred to Great Britain bodies, where we are still doing them, and commission decisions which used to be taken by the European Commission, they are now going to be taken by the Secretary of State with consent from Ministers in the Devolved Administrations. Mick: So what changes will have the greatest impact on businesses? Pierre: I’ll just run through some of the biggest changes and impacts for businesses.  Perhaps the main one is if a company wants an authorisation in both the EU and Great Britain after the end of the transition period, they’ll need to apply separately to both the EU through ECHA and Great Britain.  That also means that future European active substance approvals and product authorisations, won’t be valid in Great Britain and vice versa. A similar thing applies to active substance approval.  If you want an active substance approval in Great Britain at the end of the transitional period, you need to apply separately from any application you may be making in the EU.  The other thing is that authorisation processes for biocidal products that used to apply across European member states, won’t apply any more to Great Britain.  That means there’ll be no more mutual recognition of product authorisations between the EU and Great Britain.  EU Union authorisations won’t be valid in Great Britain after the end of the transition period and also you won’t be able to use a simplified authorisation that you had in European Union to put a product on the market in Great Britain after the transition period either. Another key thing that businesses need to be aware of is that HSE won’t be using ECHA’s IT tools, the main one being the register of biocidal products R4BP3 after the end of the transition period. And we won’t have access to ECHA’s databases anymore and what that means is that applications for biocidal product authorisations have to be sent directly to HSE, not using R4BP3 and using the HSE application forms that we’re going to put in place.   The other thing related to this is that for active substances and products to be supported in Great Britain – if you want to make an application, all the relevant data will need to be resubmitted to HSE, even if you’ve previously submitted it to ECHA.  There are transitional arrangements in the legislation that will tell you exactly when you need to do this and we’ll explain that later in this Podcast. Mick: Thanks Pierre.  Over to Nicola then.  When will the new application forms and process details be live on the HSE website Nicola and will they be different to the old forms? Nicola: Well we are completely rewriting all of the information on our website including the application forms and all of this will be published by the 1st of January.  Application forms and data will be submitted to HSE, not via R4BP as Pierre has just said but instead by HSE’s upload link and this is a secure, cloud-based platform for sharing files.  Because of the lift and shift that Pierre has also mentioned, the information required is pretty much the same as companies are used to and the data requirements are also the same. Mick: Will Great Britain have its own review programme? Nicola: Yes, after the first of January, 2021 of course, GB will be responsible for taking our own decisions on active substance approvals at our own national level and because of this, we will establish our own review programme of existing active substances.  It’s important to note that Article 89 of both the EU BPR and the new GB BPR will continue to apply.  This means that as happens now, products containing active substances which are within the scope of the GB review programme can continue to be made available on the GB market while those active substances in the products are still under the review. Other rules for participation and withdrawal from the review programme will also continue to be similar to what people are used to under the EU review programme such as things like taking over role of participant. Another issue worth pointing out here is that the priorities and the timelines of the review programme, in the GB review programme, have not yet been determined and we won’t be in a position to make those determinations until we know what the total support of active substances within GB actually is. Mick: Thanks for that Nicola.  Well, after the transition period HSE will no longer have access to the ECHA databases.  What are the implications for businesses here in the UK? Nicola: That’s correct.  After the 1st January, 2021 GB will not be permitted to access confidential information held by ECHA.   This means that any data or information that companies   previously submitted via these processes will no longer be available to us here in HSE for us to refer to, so the data will need to be resubmitted to us so that we can continue operating our own national regulatory regime.  There are deadlines for resubmission of the data and these are set out on our new GB BPR transitional arrangements and these are legally binding.  Now, HSE appreciates that the requirement for applicants to resubmit their data packages may result in an increased cost to businesses and so we are not going to charge for the work that’s necessary in the resubmitting of the data and I am talking about just the actual resubmitting and all that’s entailed around that, not the eventual evaluation of the data by us. Mick: Will the data required by the HSE be the same as that required by ECHA? Nicola: Yes it will.  The technical data requirements which must be addressed to support both the approval of an active substance and the authorisation of a biocidal product under a GB regime, will be the same as those specified under the EU regime. Mick: What’s the situation for companies which already hold the biocidal product authorisation in the UK under EU BPR – will that still be legal in the UK after the transition period? Pierre: Yes it will.  Any biocidal product authorisations and also any active substance approvals that were in place before 1st January, will remain valid in Great Britain all the way through to their expiry date whatever that was.  However, there are a couple of additional requirements which authorisation holders for biocidal products need to be aware of.   The first is that they need to be establishe

  • The duty to manage asbestos in buildings

    09/05/2024

    The duty to manage asbestos in buildings

    In this podcast, HSE experts discuss the legal obligation to manage asbestos in non-domestic buildings, highlight where asbestos is likely to be found and explain why it is dangerous. ----more---- In January 2024, HSE launched the Asbestos – Your Duty campaign, featuring updated web guidance, including new templates and explanatory videos. The steps to the legal duty to manage asbestos in buildings, and the importance of the campaign, are discussed by Tim Beaumont, HM Principal Inspector Health and Safety, Asbestos Cluster Lead and Samantha Lord,  Chartered Occupational Hygienist & Principal Specialist Inspector both from HSE.   They are joined by Craig Barker, Group Property FHS & Asbestos Manager at Marks and Spencer. During his 11 years with the company, Craig and his health and safety team have established robust ways of working to manage asbestos containing materials, developed training for employees, and put controls in place to ensure that the duty to manage asbestos is upheld and the processes are followed when any work is carried out on its buildings.   For more information and to download HSE's free asbestos management plan template, visit: https://www.hse.gov.uk/asbestos/duty/index.htm   HSE Podcast - The duty to manage asbestos in buildings transcript Host (Mick Ord):  Welcome to the HSE podcast, the latest in a series designed to help and support you because whether you are a business owner, a manager, or a worker. Health and safety is for everyone. In this episode we're taking a look at a hazardous material that has been banned in the UK for the past 25 years, but which still claims the lives of about 5, 000 people a year, more than the number of people killed on our roads. I'm Mick Ord and we're talking about asbestos. What it is, why it still causes so many deaths, how it can be managed properly and efficiently in the workplace, and what you can do to ensure that you or your employees are not exposed to it. This is all part of HSE's campaign, Asbestos - Your Duty. And, as I'm bound to mention a few times today, you can find the relevant information to help you on the Asbestos pages of HSE's website, https://www.hse.gov.uk/asbestos/duty/ With me are three people on the frontline of asbestos awareness from very practical points of view. Tim Beaumont is HSE's Principal Inspector and a Senior Policy Advisor on asbestos. He's been with HSE since 1999 in a variety of operational and policy roles. His main work right now revolves around coordinating the delivery of the recommendations arising from the Work and Pension Select Committee inquiry into HSE's management of asbestos regulation. Samantha Lord is HSE's Chartered Occupational Hygienist and Principal Specialist Inspector. She's been with HSE for 15 years. But has been working in the area of asbestos for more than 26 years. She plays an integral role in supporting and enabling HSE's asbestos-related inspection programs, as well as their asbestos campaigns. And she also regularly engages with external partners about HSE's work on asbestos. And we're delighted that Craig Barker from Marks & Spencer has joined us too. Craig has 20 years of experience consulting and advising on asbestos, with the last 10 years in the retail sector for M&S, where he's the Group Property, Fire Health and Safety and Asbestos Manager. Since 2013, M&S has completely overhauled its approach to the management of asbestos-containing materials. Sixty per cent of the estate was built before the year 2000, meaning asbestos must be considered as a potential hazard. Craig and his health and safety team have established robust ways of working, developed training programs for employees, and put controls in place for any work carried out on the building's fabrics to ensure that the duty to manage asbestos is upheld, and the correct processes are followed. Craig will talk us through their approach to managing the risks of asbestos across their estate. Welcome all. Tim, can you explain in layman's terms what asbestos is? And how it causes so many deaths.  [00:03:38] Tim Beaumont:  Well, thanks, Mick. That's a really important question. Asbestos is a naturally occurring mineral. When we say asbestos, actually there are a number of different types of asbestos. They're all found in the ground naturally and over many years we've been removing it. It has a number of different qualities that make it rather useful. First of all, it's cheap, it's widely distributed across the globe and easy to get to. Secondly, it's a really good fire retardant. Thirdly, it's a really good insulating material. So, for those three reasons, it has been used widely in construction, particularly over the last 150 years or so, but most of all, the second half of the 20th century. It's got these wonderful attributes that meant that it was cert to be used in a huge range of structures and properties to insulate and to prevent the spread of fire. The final thing about it, it's really easy to manipulate. You can weave it, you can turn it into a kind of cement, you can add it to other things, you can put it into other products that you're making. All of these things make it an incredibly attractive and useful material. The massive, massive downside. It, um, forms tiny, tiny little shards, little fibres that are really easy to breathe in. They go right into the very depths of your lungs, and that's the point where it causes ill health. These tiny little shards, these tiny little fibres, so small that you need incredibly strong microscopes to see, end up causing cancers, lung cancer, but particularly an unusual cancer called mesothelioma. And it's this cancer that is absolutely linked to asbestos exposure. So, really useful, but also really deadly.  [00:05:34] Host (Mick Ord):  And mesothelioma, I believe that causes two and a half thousand deaths a year in the UK. I mean, that's astonishing, isn't it?  [00:05:42] Tim Beaumont:  That is a very high number. It's one of the highest causes of death, particularly in men. The thing about mesothelioma and lung cancer caused by asbestos is the time delay between being exposed and actually developing the cancer. It can be a number of decades, around about 40 years or so, between being exposed to the asbestos and developing the cancer. [00:06:06] Host (Mick Ord):  Tim, is there a safe level of asbestos exposure? [00:06:11] Tim Beaumont:  Well, what we're not able to say, we're not able to establish a line In exposure above which you're going to be exposed and it's going to harm your health and below which you're going to be safe That just doesn't exist for asbestos because of the nature of its fibrous exposure type What we are trying to do is ensure that Any material that contains asbestos does not give rise to fibres, and that's the crucial thing with asbestos, the breathable fibres that you might be exposed to. So that's the focus of our attention when it comes to asbestos management.  [00:06:46] Host (Mick Ord):  Also, Tim, what buildings may contain asbestos and where can it be found? [00:06:51] Tim Beaumont:  Asbestos can be found in any building that's been built, particularly in the 20th century, leading up to 1999, when it was banned from use in construction. But particularly the period from 1920s, 1930s, up to the mid-80s, you're most likely to find asbestos. And it can be found in literally any building or structure that was built in that time period. So, offices, Schools, hospitals, shops, warehouses and homes may all contain asbestos in different ways. Now on our website, we've got an excellent little picture of a property that shows you where you might find asbestos within that property. But I just want to be clear, for the benefit of this conversation we're having, we're talking about non-domestic setting. That's because there's a very specific set of legislation and standards in place to for working with asbestos in the non-domestic setting. So, everything you're going to be hearing us talk about today, we're thinking about workplaces in particular. And that is the focus of the work of the Health and Safety Executive. We want to make sure that in workplaces, exposure to asbestos is properly controlled so that when you go to work, you are not going to be exposed to asbestos fibres.  [00:08:05] Host (Mick Ord):  Sam, what are the steps to managing asbestos properly? What advice say would you give to a new duty holder operating in an older building? [00:08:13] Samantha Lord:  Essentially, if you've got an older building, the first thing you need to do is establish if asbestos could be present. Then what you've got to do is identify the risk from that asbestos. And the reason why I say that is that all the asbestos materials don't have the same risk. So as Tim sort of alluded to, there's a range of different products, but their risk is to do with their inherent properties. Some materials are quite what we call friable, and they easily release fibres if they're disturbed, or if they actually deteriorate over time. But some are much sort of hard-wearing, such as floor tiles. And you're really going to struggle to get fibre released from those. So, it's important to understand the difference in risk associated with different products. The other thing that's going to affect the risk is how people processes, maintenance and cleaning sort of happens within that building. So, all the activities that potentially could what we call disturb the asbestos. Because once you disturb asbestos, that is where you'll break down the material and release those fibres. So, once you've identified the risk, then you've got to manage those risks to make sure no one is exposed. And that's really what we're all here to do. What's Duty to Manage is essentially for. So, I've started off just introducing a

  • الديون وصندوق النقد الدولي مع د. خالد صقر | بودكاست الحل إيه؟

    5 Jun

    الديون وصندوق النقد الدولي مع د. خالد صقر | بودكاست الحل إيه؟

    يوشك برنامج التسهيل الائتماني الذي قدمه صندوق النقد الدولي على الانتهاء؛ فهل يمكننا اليوم تقييم تجربة مصر مع البرنامج والصندوق وخطوات الإصلاح الاقتصادى؟ في هذه الحلقة من بودكاست الحل أيه؟ مع د. رباب المهدي، نستضيف د. خالد صقر، الخبير الدولي في هندسة برامج الإصلاح الاقتصادي، ورئيس بعثة سابق في صندوق النقد الدولي، لنناقشه في مدى نجاح مصر في تحقيق أهداف البرنامج، والحلول المقترحة لإدارة الدين العام، وكيف نتجنب اللجوء إلى المزيد من القروض. Hosted on Acast. See acast.com/privacy for more information.

  • المثقفون والسلطة في مصر مع الأديب المصري محمد سلماوي | بودكاست الحل أيه؟

    22 May

    المثقفون والسلطة في مصر مع الأديب المصري محمد سلماوي | بودكاست الحل أيه؟

    في أوقات ازدهار الثقافة المصرية، ظهر إنتاج فني عالي المستوى، وبزغ نجم مثقفين مصريين كان لهم ثقل، وقدرة على التأثير في الدولة والمجتمع وجزء من قوة مصر الناعمة، اليوم أصبح هذا الدور غائب. في هذه الحلقة بودكاست #الحل_إيه؟ مع د. رباب المهدي، نستضيف الأديب المصري محمد سلماوي، الرئيس الأسبق لاتحاد كتاب مصر، وعضو لجنة تعديل الدستور ٢٠١٣، لنفتح معه ملف دور المثقفين في المجتمع، وتراجع هامش الحرية، والعلاقة المعقدة بين الثقافة والسلطة في مصر. Hosted on Acast. See acast.com/privacy for more information.

  • ماتش مصر وبلجيكا

    17 Jun

    ماتش مصر وبلجيكا

    وقف اطلاق النار

  • بودكاست الحل إيه؟ مع د. رباب المهدي | اضطراب تشتت الانتباه وفرط الحركة (ADD/ADHD) مع د.هناء سليمان

    26/12/2025

    بودكاست الحل إيه؟ مع د. رباب المهدي | اضطراب تشتت الانتباه وفرط الحركة (ADD/ADHD) مع د.هناء سليمان

    في هذه الحلقة من الحل إيه؟، تستضيف د. رباب المهدي استشاري الطب النفسي بالمملكة المتحدة وخبيرة اضطراب قصور الانتباه وفرط الحركة د. هناء سليمان، في حوار معمّق حول اضطراب تشتت الانتباه وفرط الحركة (ADD / ADHD)، بعيدًا عن الصور النمطية الشائعة والاختزال المخل.هل هي أمراض يجب علاجها، أم اختلاف عصبي في طريقة عمل الدماغ؟وتمتد المناقشة لتشمل تعريف الانتباه نفسه، وطيف الأعراض، والفرق بين تشتت الانتباه وفرط الحركة، ولماذا يُساء تشخيص الاضطراب أو يُغفل تمامًا. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.comfor information about our collection and use of personal data foradvertising. Hosted on Acast. See acast.com/privacy for more information.

New Shows

  • Explicit, War Desk
    News
    News

    Series

  • Podcast AlTanmiya | بودكاست التنمية
    Government
    Government

    Monthly

  • + NOW السودان
    Government
    Government

    Updated weekly

  • The Reform UK Podcast
    Politics
    Politics

    Updated weekly

  • American Credo
    Politics
    Politics

    Complete

  • Anti-Coup
    Politics
    Politics

    Complete

  • Barakatna
    Government
    Government

    Updated 27 Jul

  • Français (France)
  • العربية
Select a country or region

Africa, Middle East, and India

  • Algeria
  • Angola
  • Armenia
  • Azerbaijan
  • Bahrain
  • Benin
  • Botswana
  • Burkina Faso
  • Cameroun
  • Cape Verde
  • Chad
  • Côte d’Ivoire
  • Congo, The Democratic Republic Of The
  • Egypt
  • Eswatini
  • Gabon
  • Gambia
  • Ghana
  • Guinea-Bissau
  • India
  • Iraq
  • Israel
  • Jordan
  • Kenya
  • Kuwait
  • Lebanon
  • Liberia
  • Libya
  • Madagascar
  • Malawi
  • Mali
  • Mauritania
  • Mauritius
  • Morocco
  • Mozambique
  • Namibia
  • Niger (English)
  • Nigeria
  • Oman
  • Qatar
  • Congo, Republic of
  • Rwanda
  • São Tomé and Príncipe
  • Saudi Arabia
  • Senegal
  • Seychelles
  • Sierra Leone
  • South Africa
  • Sri Lanka
  • Tajikistan
  • Tanzania, United Republic Of
  • Tunisia
  • Turkmenistan
  • United Arab Emirates
  • Uganda
  • Yemen
  • Zambia
  • Zimbabwe

Asia Pacific

  • Afghanistan
  • Australia
  • Bhutan
  • Brunei Darussalam
  • Cambodia
  • 中国大陆
  • Fiji
  • 香港
  • Indonesia (English)
  • 日本
  • Kazakhstan
  • 대한민국
  • Kyrgyzstan
  • Lao People's Democratic Republic
  • 澳門
  • Malaysia (English)
  • Maldives
  • Micronesia, Federated States of
  • Mongolia
  • Myanmar
  • Nauru
  • Nepal
  • New Zealand
  • Pakistan
  • Palau
  • Papua New Guinea
  • Philippines
  • Singapore
  • Solomon Islands
  • 台灣
  • Thailand
  • Tonga
  • Turkmenistan
  • Uzbekistan
  • Vanuatu
  • Vietnam

Europe

  • Albania
  • Armenia
  • Österreich
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France (Français)
  • Georgia
  • Deutschland
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italia
  • Kosovo
  • Latvia
  • Lithuania
  • Luxembourg (English)
  • Malta
  • Moldova, Republic Of
  • Montenegro
  • Nederland
  • North Macedonia
  • Norway
  • Poland
  • Portugal (Português)
  • Romania
  • Россия
  • Serbia
  • Slovakia
  • Slovenia
  • España
  • Sverige
  • Schweiz
  • Türkiye (English)
  • Ukraine
  • United Kingdom

Latin America and the Caribbean

  • Anguilla
  • Antigua and Barbuda
  • Argentina (Español)
  • Bahamas
  • Barbados
  • Belize
  • Bermuda
  • Bolivia (Español)
  • Brasil
  • Virgin Islands, British
  • Cayman Islands
  • Chile (Español)
  • Colombia (Español)
  • Costa Rica (Español)
  • Dominica
  • República Dominicana
  • Ecuador (Español)
  • El Salvador (Español)
  • Grenada
  • Guatemala (Español)
  • Guyana
  • Honduras (Español)
  • Jamaica
  • México
  • Montserrat
  • Nicaragua (Español)
  • Panamá
  • Paraguay (Español)
  • Perú
  • St. Kitts and Nevis
  • Saint Lucia
  • St. Vincent and The Grenadines
  • Suriname
  • Trinidad and Tobago
  • Turks and Caicos
  • Uruguay (English)
  • Venezuela (Español)

The United States and Canada

  • Canada (English)
  • Canada (Français)
  • United States
  • Estados Unidos (Español México)
  • الولايات المتحدة
  • США
  • 美国 (简体中文)
  • États-Unis (Français France)
  • 미국
  • Estados Unidos (Português Brasil)
  • Hoa Kỳ
  • 美國 (繁體中文台灣)

Copyright © 2026 Apple Inc. All rights reserved.

  • Internet Service Terms
  • Apple Podcasts web player & Privacy
  • Cookie Warning
  • Support
  • Feedback

To listen to explicit episodes, sign in.

Apple Podcasts

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.

Select a country or region

Africa, Middle East, and India

  • Algeria
  • Angola
  • Armenia
  • Azerbaijan
  • Bahrain
  • Benin
  • Botswana
  • Burkina Faso
  • Cameroun
  • Cape Verde
  • Chad
  • Côte d’Ivoire
  • Congo, The Democratic Republic Of The
  • Egypt
  • Eswatini
  • Gabon
  • Gambia
  • Ghana
  • Guinea-Bissau
  • India
  • Iraq
  • Israel
  • Jordan
  • Kenya
  • Kuwait
  • Lebanon
  • Liberia
  • Libya
  • Madagascar
  • Malawi
  • Mali
  • Mauritania
  • Mauritius
  • Morocco
  • Mozambique
  • Namibia
  • Niger (English)
  • Nigeria
  • Oman
  • Qatar
  • Congo, Republic of
  • Rwanda
  • São Tomé and Príncipe
  • Saudi Arabia
  • Senegal
  • Seychelles
  • Sierra Leone
  • South Africa
  • Sri Lanka
  • Tajikistan
  • Tanzania, United Republic Of
  • Tunisia
  • Turkmenistan
  • United Arab Emirates
  • Uganda
  • Yemen
  • Zambia
  • Zimbabwe

Asia Pacific

  • Afghanistan
  • Australia
  • Bhutan
  • Brunei Darussalam
  • Cambodia
  • 中国大陆
  • Fiji
  • 香港
  • Indonesia (English)
  • 日本
  • Kazakhstan
  • 대한민국
  • Kyrgyzstan
  • Lao People's Democratic Republic
  • 澳門
  • Malaysia (English)
  • Maldives
  • Micronesia, Federated States of
  • Mongolia
  • Myanmar
  • Nauru
  • Nepal
  • New Zealand
  • Pakistan
  • Palau
  • Papua New Guinea
  • Philippines
  • Singapore
  • Solomon Islands
  • 台灣
  • Thailand
  • Tonga
  • Turkmenistan
  • Uzbekistan
  • Vanuatu
  • Vietnam

Europe

  • Albania
  • Armenia
  • Österreich
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France (Français)
  • Georgia
  • Deutschland
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italia
  • Kosovo
  • Latvia
  • Lithuania
  • Luxembourg (English)
  • Malta
  • Moldova, Republic Of
  • Montenegro
  • Nederland
  • North Macedonia
  • Norway
  • Poland
  • Portugal (Português)
  • Romania
  • Россия
  • Serbia
  • Slovakia
  • Slovenia
  • España
  • Sverige
  • Schweiz
  • Türkiye (English)
  • Ukraine
  • United Kingdom

Latin America and the Caribbean

  • Anguilla
  • Antigua and Barbuda
  • Argentina (Español)
  • Bahamas
  • Barbados
  • Belize
  • Bermuda
  • Bolivia (Español)
  • Brasil
  • Virgin Islands, British
  • Cayman Islands
  • Chile (Español)
  • Colombia (Español)
  • Costa Rica (Español)
  • Dominica
  • República Dominicana
  • Ecuador (Español)
  • El Salvador (Español)
  • Grenada
  • Guatemala (Español)
  • Guyana
  • Honduras (Español)
  • Jamaica
  • México
  • Montserrat
  • Nicaragua (Español)
  • Panamá
  • Paraguay (Español)
  • Perú
  • St. Kitts and Nevis
  • Saint Lucia
  • St. Vincent and The Grenadines
  • Suriname
  • Trinidad and Tobago
  • Turks and Caicos
  • Uruguay (English)
  • Venezuela (Español)

The United States and Canada

  • Canada (English)
  • Canada (Français)
  • United States
  • Estados Unidos (Español México)
  • الولايات المتحدة
  • США
  • 美国 (简体中文)
  • États-Unis (Français France)
  • 미국
  • Estados Unidos (Português Brasil)
  • Hoa Kỳ
  • 美國 (繁體中文台灣)